...
首页> 外文期刊>Journal of Veterinary Pharmacology and Therapeutics >Pharmacokinetics of fentanyl, alfentanil, and sufentanil in isoflurane-anesthetized cats.
【24h】

Pharmacokinetics of fentanyl, alfentanil, and sufentanil in isoflurane-anesthetized cats.

机译:芬太尼麻醉的猫中的芬太尼,阿芬太尼和舒芬太尼的药代动力学。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

The aim of this study was to compare the pharmacokinetics of fentanyl, alfentanil, and sufentanil in isoflurane-anesthetized cats. Six adult cats were used. Anesthesia was induced and maintained with isoflurane in oxygen. End-tidal isoflurane concentration was set at 2% and adjusted as required due to spontaneous movement. Fentanyl (10 micro g/kg), alfentanil (100 micro g/kg), or sufentanil (1 micro g/kg) was administered intravenously as a bolus, on separate days. Blood samples were collected immediately before and for 8 h following drug administration. Plasma drug concentration was determined using liquid chromatography/mass spectrometry. Compartment models were fitted to concentration-time data. A 3-compartment model best fitted the concentration-time data for all drugs, except for 1 cat in the sufentanil group (excluded from analysis). The volume of the central compartment and the volume of distribution at steady-state (L/kg) [mean+or-SEM (range)], the clearance (mL/min/kg) [harmonic mean+or-pseudo-SD (range)], and the terminal half-life (min) [median (range)] were 0.25+or-0.04 (0.09-0.34), 2.18+or-0.16 (1.79-2.83), 18.6+or-5.0 (15-29.8), and 151 (115-211) for fentanyl; 0.10+or-0.01 (0.07-0.14), 0.89+or-0.16 (0.68-1.83), 11.6+or-2.6 (9.2-15.8), and 144 (118-501) for alfentanil; and 0.06+or-0.01 (0.04-0.10), 0.77+or-0.07 (0.63-0.99), 17.6+or-4.3 (13.9-24.3), and 54 (46-76) for sufentanil. Differences in clearance and volume of distribution result in similar terminal half-lives for fentanyl and alfentanil, longer than for sufentanil.
机译:这项研究的目的是比较在异氟烷麻醉的猫中芬太尼,阿芬太尼和舒芬太尼的药代动力学。使用了六只成年猫。用氧中的异氟烷诱导并维持麻醉。潮气末异氟烷的浓度设置为2%,并由于自发移动而根据需要进行调整。分别在几天内静脉注射芬太尼(10 micro g / kg),阿芬太尼(100 micro g / kg)或舒芬太尼(1 micro g / kg)。在给药前和给药后8小时立即采集血样。使用液相色谱/质谱法测定血浆药物浓度。隔室模型适合于集中时间数据。三室模型最适合所有药物的浓度-时间数据,舒芬太尼组中的一只猫除外(从分析中排除)。中央隔室的体积和稳态下的分布体积(L / kg)[平均值+或SEM(范围)],清除率(mL / min / kg)[谐波平均值+或-伪SD(范围)和最终半衰期(分钟)[中位数(范围)]分别为0.25+或-0.04(0.09-0.34),2.18 +或-0.16(1.79-2.83),18.6 +或-5.0(15- 29.8)和芬太尼151(115-211);阿芬太尼:0.10+或-0.01(0.07-0.14),0.89 +或-0.16(0.68-1.83),11.6 +或-2.6(9.2-15.8)和144(118-501);舒芬太尼分别为0.06+或-0.01(0.04-0.10),0.77 +或-0.07(0.63-0.99),17.6 +或-4.3(13.9-24.3)和54(46-76)。清除率和分布量的差异导致芬太尼和阿芬太尼的终末半衰期相近,比舒芬太尼的终末半衰期长。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号